Target Product Profiles & Platform Target Profiles
If you do not know where you are going, how do you get there? A Target Product Profile answers that question. It defines what your drug should look like at market approval and serves as the foundation of every successful development program.
What Is a Target Product Profile?
A Target Product Profile (TPP) is a strategic document that describes the desired characteristics of a drug product at market approval. It serves as the north star for your entire development program.
A TPP clarifies the disease or disorder you intend to treat, the patient population, mechanism of action, efficacy and safety profile, administration method, quality standards, go/no-go criteria, and evidence gaps. Every one of these elements drives a decision. Every decision shapes your roadmap.
Like a fine wine that must age to reach maturity, a TPP becomes more refined as you generate more data and insights into your desired patient population. It starts as a hypothesis. It matures into a navigation tool.
What Is a Platform Target Profile?
A Platform Target Profile (PTP) defines the desired characteristics of a drug delivery system or personalized therapy platform, rather than a single drug product. Where a TPP describes one product, a PTP describes the technology engine that can generate multiple products.
PTPs matter for teams building gene therapy vectors, nanoparticle delivery systems, cell therapy platforms, or personalized medicine approaches. The PTP captures scalability parameters, manufacturing consistency, personalization criteria, and the regulatory pathway for platform-level characterization.
Most emerging biopharma teams need both. The PTP defines the platform. The TPP defines each product that runs on that platform. Together, they create clarity for your team, your investors, and your regulators.
Anatomy of a TPP
What a Target Product Profile actually looks like
Every attribute is a decision. Some you make at the start; others mature with the data. The sheet below is illustrative — yours is built around your candidate.
Target Product Profile
Sample — Anatomy of a TPP
Document Version
v0.1 — draft
- Indication
Drug-resistant tuberculosis (MDR-TB)
Sample case — illustrative only
- Patient Population
Adults, treatment-refractory, HIV co-infection permitted
- Mechanism of Action
Inhibitor of mycobacterial ATP synthase
- Route of Administration
Oral, once-daily
- Efficacy Endpoint
≥85% culture conversion at 8 weeks
vs. standard-of-care baseline ~60%
- Safety / Tolerability
No grade ≥3 hepatotoxicity; QTc Δ < 30ms at therapeutic dose
- Manufacturing
- Pending discoveryManufacturing — pending discovery during the engagement
- Commercial Positioning
- Pending discoveryCommercial Positioning — pending discovery during the engagement
Living document
Refined with each data milestone — Discovery → Phase I
Strategic Value of a TPP
Without a TPP, teams make decisions in silos. Chemistry sets one target, clinical sets another, regulatory expects something else. The result is a misaligned program that wastes time and capital. A strong TPP prevents that.
Forces Explicit Choices
No ambiguity. Every stakeholder sees the same target efficacy, the same safety thresholds, the same patient population.
Sets Go/No-Go Criteria
Defines the evidence thresholds that determine whether your program advances or pivots. No more guessing.
Aligns All Planning
R&D, clinical, regulatory, commercial. One document aligns every function around a single achievable vision of success.
Sharpens Investor Narrative
Investors fund clarity. A rigorous TPP demonstrates that your team knows the destination and the roadmap to reach it.
Living Document
The TPP evolves as new evidence emerges. It absorbs data, closes gaps, and sharpens with every development milestone.
Key Components of a TPP & PTP
Six domains define a complete profile. The first five apply to every TPP. The sixth addresses platform-specific elements for PTPs.
Indication & Population
- Target disease or disorder
- Patient population definition
- Unmet medical need and evidence gaps
- Epidemiology and burden of illness
Efficacy & Safety
- Primary efficacy endpoints
- Minimum acceptable efficacy thresholds
- Safety and tolerability profile
- Risk-benefit assessment framework
Product Characteristics
- Dosage form and route of administration
- Dosing regimen and compliance factors
- Shelf life, storage, and quality standards
- Manufacturing and scalability considerations
Regulatory & Commercial
- Regulatory classification and pathway
- Label claim objectives
- Competitive differentiation and positioning
- Pricing, reimbursement, and market access
Clinical Development
- Phase I through III design alignment
- Biomarker strategy and endpoint justification
- Comparator selection rationale
- Go/no-go criteria at each stage gate
Platform-Specific (PTP)
- Platform characterization and mechanism
- Scalability and manufacturing consistency
- Personalization criteria and adaptability
- Technology differentiation across indications
Frequently Asked Questions
Define Your Product's Journey
Whether you are building your first TPP, developing a PTP for a platform technology, or refining an existing profile, we bring the clarity and execution rigor to get it right.
Book a Free Strategy Call